Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DREAM: Ramipril and Rosiglitazone for Diabetes Prevention
NCT00095654Phase 3Completed
- Start
- Jul 2001
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of ramipril, rosiglitazone in type 2 diabetes mellitus (T2DM). Started Jul 2001; status: completed.
02
Drugs
ramiprilrosiglitazone
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00095654.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00095654.